share_log

3M | 8-K: 3M Completes Spin-off of Solventum

3M | 8-K: Current report

3M | 8-K:重大事件
美股SEC公告 ·  04/04 08:20

Moomoo AI 已提取核心訊息

On April 1, 2024, 3M Company successfully completed the spin-off of its health care business, now known as Solventum Corporation. This strategic move resulted in the distribution of 80.1% of Solventum's outstanding shares to 3M's shareholders, with the distribution occurring at 3:30 a.m. Eastern Time on the same day. Shareholders of 3M as of March 18, 2024, received one share of Solventum for every four shares of 3M they owned, with cash paid out for fractional shares. Solventum's common stock has begun trading on the New York Stock Exchange under the ticker 'SOLV'. In preparation for this separation, 3M and Solventum entered into several agreements to outline the ongoing relationship between the two entities, including a Separation and Distribution Agreement and various other agreements covering transition services, tax matters, employee issues, and intellectual property licensing. These agreements were detailed in Solventum's Information Statement filed with the SEC on March 13, 2024. Additionally, 3M was released from all obligations under its guarantee of certain senior unsubordinated notes issued by Solventum upon the completion of the distribution.
On April 1, 2024, 3M Company successfully completed the spin-off of its health care business, now known as Solventum Corporation. This strategic move resulted in the distribution of 80.1% of Solventum's outstanding shares to 3M's shareholders, with the distribution occurring at 3:30 a.m. Eastern Time on the same day. Shareholders of 3M as of March 18, 2024, received one share of Solventum for every four shares of 3M they owned, with cash paid out for fractional shares. Solventum's common stock has begun trading on the New York Stock Exchange under the ticker 'SOLV'. In preparation for this separation, 3M and Solventum entered into several agreements to outline the ongoing relationship between the two entities, including a Separation and Distribution Agreement and various other agreements covering transition services, tax matters, employee issues, and intellectual property licensing. These agreements were detailed in Solventum's Information Statement filed with the SEC on March 13, 2024. Additionally, 3M was released from all obligations under its guarantee of certain senior unsubordinated notes issued by Solventum upon the completion of the distribution.
2024年4月1日,3M公司成功完成了其醫療保健業務(現名爲Solventum Corporation)的分拆工作。這一戰略舉措使Solventum的80.1%的已發行股份分配給了3M的股東,分配將於美國東部時間當天凌晨 3:30 進行。截至2024年3月18日,3M的股東每持有3M的四股股份將獲得一股Solventum的股份,現金用於支付部分股份。Solventum的普通股已開始在紐約證券交易所上市,股票代碼爲 “SOLV”。爲準備分離,3M和Solventum簽訂了幾項協議,概述了這兩個實體之間的持續關係,包括分離和分銷協議以及涵蓋過渡服務、稅務事務、員工問題和知識產權許可的其他各種協議。Solventum於2024年3月13日向美國證券交易委員會提交的信息聲明中詳細介紹了這些協議。此外,3M在分發完成後免除了Solventum發行的某些優先非次級票據的擔保義務。
2024年4月1日,3M公司成功完成了其醫療保健業務(現名爲Solventum Corporation)的分拆工作。這一戰略舉措使Solventum的80.1%的已發行股份分配給了3M的股東,分配將於美國東部時間當天凌晨 3:30 進行。截至2024年3月18日,3M的股東每持有3M的四股股份將獲得一股Solventum的股份,現金用於支付部分股份。Solventum的普通股已開始在紐約證券交易所上市,股票代碼爲 “SOLV”。爲準備分離,3M和Solventum簽訂了幾項協議,概述了這兩個實體之間的持續關係,包括分離和分銷協議以及涵蓋過渡服務、稅務事務、員工問題和知識產權許可的其他各種協議。Solventum於2024年3月13日向美國證券交易委員會提交的信息聲明中詳細介紹了這些協議。此外,3M在分發完成後免除了Solventum發行的某些優先非次級票據的擔保義務。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息